A closer look at Sinopharm, Thailand’s first alternative vaccine

13 Sept 19:46 Key points summarised by AI

Thailand's FDA approved Sinopharm as its fifth COVID-19 vaccine, with the Chulabhorn Royal Academy set to import 1 million doses by June as the country's first alternative jab.
The WHO-approved, two-dose Sinopharm vaccine demonstrates 79% efficacy against symptomatic COVID-19 and hospitalization, though its effectiveness against emerging variants remains under investigation.
The Sinopharm vaccine will be available for purchase at approximately Bt1,000 per dose, including insurance, and will be distributed to interested agencies and individuals without profit from the Chulabhorn Royal Academy.

Speculation growing over merger between Bhumjaithai and Kla Tham parties

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.